USP9X and prostate cancer: In vitro prostate cancer cell line studies showed that the depletion of USP9X resulted in increased cell migration and invasion, which was achieved by the upregulated expression of ERK-mediated MMP9 and phosphorylated dynamin-related protein 1 (DRP1) [117].